Talpheraincis A Specialty Pharmaceutical Company Based In San Mateocaliforniafounded In 2005The Company Rebranded From Acelrx Pharmaceuticals In January 2024 To Reflect Its Mission Of Developing Innovative Therapies For Medically Supervised Settingstalphera Aims To Enhance Patient Care By Providing Quality Tools For Healthcare Providers The Company S Product Pipeline Includes Several Key Candidatesniyad Is A Lyophilized Formulation Of Nafamostat For Use As A Regional Anticoagulant In Dialysis Circuitsltx 608 Has Potential Applications For Anti Inflammatory And Antiviral Treatmentsfedsyra Is A Pre Filled Ephedrine Syringe For Managing Hypotension During General Anesthesiawhile Pfs 02 Is A Pre Filled Phenylephrine Syringe For Treating Hypotension And Clotting Disorders Talphera Is Open To Partnerships And Collaborationsencouraging Potential Partners To Reach Out For Discussionsthe Company Is Led By Ceo Vincent Angottiwith A Team Focused On Advancing Its Product Offerings In Healthcare Settings
